Sorbi, C.; Belluti, S.; Atene, C.G.; Marocchi, F.; Linciano, P.; Roy, N.; Paradiso, E.; Casarini, L.; Ronsisvalle, S.; Zanocco-Marani, T.;
et al. BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting. Int. J. Mol. Sci. 2023, 24, 9684.
https://doi.org/10.3390/ijms24119684
AMA Style
Sorbi C, Belluti S, Atene CG, Marocchi F, Linciano P, Roy N, Paradiso E, Casarini L, Ronsisvalle S, Zanocco-Marani T,
et al. BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting. International Journal of Molecular Sciences. 2023; 24(11):9684.
https://doi.org/10.3390/ijms24119684
Chicago/Turabian Style
Sorbi, Claudia, Silvia Belluti, Claudio Giacinto Atene, Federica Marocchi, Pasquale Linciano, Neena Roy, Elia Paradiso, Livio Casarini, Simone Ronsisvalle, Tommaso Zanocco-Marani,
and et al. 2023. "BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting" International Journal of Molecular Sciences 24, no. 11: 9684.
https://doi.org/10.3390/ijms24119684
APA Style
Sorbi, C., Belluti, S., Atene, C. G., Marocchi, F., Linciano, P., Roy, N., Paradiso, E., Casarini, L., Ronsisvalle, S., Zanocco-Marani, T., Brasili, L., Lanfrancone, L., Imbriano, C., Di Rocco, G., & Franchini, S.
(2023). BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting. International Journal of Molecular Sciences, 24(11), 9684.
https://doi.org/10.3390/ijms24119684
